Health Administration Press
Strategic Analysis for Healthcare
Chapter 25
Copyright © 2016 Foundation of the American
College of Healthcare Executives. Not for sale.
Health Administration Press
Strategy Selection
• To begin the process of strategy selection, the analyst reviews the
potential strategies identified in the Ansoff and TOWS matrices.
• Many strategists place each possible strategy on a separate sticky
note, so the strategies can be sorted and moved around into clusters.
• The strategist searches for commonalities among the strategies.
• Most likely, about 25 strategies can be grouped under four or five
main headings.
• The strategist identifies those main headings and places the
appropriate strategies under each.
• The main headings become “overarching strategies,” and the specific
strategies from the Ansoff and TOWS matrices become “supporting
strategies” or “substrategies.”
Copyright © 2016 Foundation of the American
College of Healthcare Executives. Not for sale.
Health Administration Press
Strategy Selection
• In a strategy consolidation from the Ansoff and TOWS
matrices, “Expand into adjacent counties,” “Expand
into urgent care,” “Place satellite locations,” “Open
cancer center,” and “Buy out private practices” could
all be grouped together.
• A title of “Facility Expansion” could be placed above
these strategies, and that could become an overarching
strategy.
• Likewise, many Ansoff and TOWS example strategies
could be consolidated under other overarching
strategies, such as “Service Expansion,” for instance.
Copyright © 2016 Foundation of the American
College of Healthcare Executives. Not for sale.
Health Administration Press
Strategy Selection
• Pursuing every good strategy is not
recommended.
• An organization likely will not have sufficient
funds to pursue every option, and doing so would
lead to a lack of focus.
• The strategic options need to be culled and the
most promising ones retained.
• After the strategies have been consolidated, the
analyst can evaluate the strategies at two levels.
Copyright © 2016 Foundation of the American
College of Healthcare Executives. Not for sale.
Health Administration Press
Strategy Selection
• First, the overarching strategies can be compared
against one another.
• For example, the facility expansion strategy would be
compared with service expansion.
• At the second level, the substrategies under an
overarching strategy can be evaluated and then either
retained or discarded.
• In the facility expansion example, the analyst would
decide whether to retain or discard “Expand into
adjacent counties,” “Expand into urgent care,” “Place
satellite locations,” “Open cancer center,” and “Buy out
private practices.”
Copyright © 2016 Foundation of the American
College of Healthcare Executives. Not for sale.
Health Administration Press
Strategic Fit Assessment
and the QSPM
• To choose among the overarching strategies, the
strategist constructs a quantitative strategic planning
matrix (QSPM).
• This matrix assesses each overarching strategy based
on how attractive it is relative to the external factor
evaluation (EFE) and internal factor evaluation (IFE)
factors (see Chapters 10 and 18).
• This assessment produces an attractiveness score (AS)
and a total attractiveness score (TAS) for each strategy.
• The strategy with the highest total attractiveness score
is the strategy considered most appropriate for
implementation.
Copyright © 2016 Foundation of the American
College of Healthcare Executives. Not for sale.
Health Administration Press
QSPM
• To create the QSPM, place the external
opportunities and threats from the EFE
analysis and the internal strengths and
weaknesses from the IFE analysis into the left
column of the matrix.
• Make sure you list at least ten external factors
and ten internal factors. Include the weight
from the IFE and EFE with each item.
Copyright © 2016 Foundation of the American
College of Healthcare Executives. Not for sale.
Health Administration Press
QSPM
• The attractiveness score in the QSPM indicates whether
each IFE/EFE factor is important to, has a significant
impact on, or produces an “attractive” match with each
strategy.
• The scores are determined by analyzing each IFE/EFE
factor and considering whether the factor makes a
difference in the decision of which strategy to pursue.
• If the factor does not make a difference, the
attractiveness score is zero.
• If the factor does make a difference, the strategy is
rated relative to that factor.
Copyright © 2016 Foundation of the American
College of Healthcare Executives. Not for sale.
Health Administration Press
QSPM
• The rating scale, from 0 to 4, is as follows:
1 = not attractive
2 = somewhat attractive
3 = reasonably attractive
4 = highly attractive
0 = not applicable
• The strategist assigns the attractiveness score
based upon everything known about the
organization and its competitive environment.
Copyright © 2016 Foundation of the American
College of Healthcare Executives. Not for sale.
Health Administration Press
QSPM
• As an example on the next slide, the
overarching strategy of facility expansion is
compared to service expansion.
• The weight multiplied by the attractiveness
score assigned by the strategist yields the total
attractiveness score.
Copyright © 2016 Foundation of the American
College of Healthcare Executives. Not for sale.
Health Administration Press
QSPM
Opportunities
1 Expansion of Existing Services
2 Additional Locations
3 Greater Exposure and Branding
4 Addition of Trauma Center
Weight
0.050
0.100
0.050
0.025
Total
Attractiveness
Score
Attractiveness
Score
Service Expansion
Total
Attractiveness
Score
Opportunities
Attractiveness
Score
Weight
Facility Expansion
3
0.150
4
0.200
4
0.400
4
0.400
4
0.200
3
0.150
4
0.100
4
0.100
Copyright © 2016 Foundation of the American
College of Healthcare Executives. Not for sale.
Health Administration Press
QSPM
• The entire IFE and EFE, containing all of the
strengths, weaknesses, opportunities, and threats
and their corresponding weights, is used.
• Each item is issued an attractiveness score.
• The attractiveness score is multiplied by the
weight to arrive at a total attractiveness score.
• The entire total attractiveness score column is
summed for each strategy individually.
• The strategy with the highest TAS is the strategy
that is quantitatively most attractive and thus
selected.
Copyright © 2016 Foundation of the American
College of Healthcare Executives. Not for sale.
Health Administration Press
Assessing the Supporting Strategies
• The supporting strategies within the overarching strategy
can be assessed next.
• Not all the supporting strategies will be appropriate, and
some may be mutually exclusive.
• Many strategists run a QSPM again on the supporting
strategies and retain those with the highest scores.
• Other analysts use research and intuition to determine
which ones stay and which go.
• The cost of implementing one supporting strategy might
affect how many other strategies the company can afford to
take on.
• At the same time, multiple supporting strategies might be
necessary for successful completion of the overarching
strategy.
Copyright © 2016 Foundation of the American
College of Healthcare Executives. Not for sale.
Health Administration Press
Consistency Check
• Once strategies have been selected, they should
be checked for consistency with the directional
matrices discussed in previous chapters.
• If the grand strategy matrix, SPACE matrix, and
internal–external (I/E) matrix suggest a
conservative strategy and the strategist has chosen
an aggressive overarching strategy with
aggressive supporting strategies, then something
is wrong.
• The inputs and decision making may need to be
reconsidered.
Copyright © 2016 Foundation of the American
College of Healthcare Executives. Not for sale.
Running head: JOHNSON AND JOHNSON COMPANY
Choose An Organization
Johnson and Johnson Company
JOHNSON AND JOHNSON COMPANY.
2
Johnson and Johnson Company
Johnson and Johnson is an American intercontinental company which deals with the
manufacture of medical equipment, pharmaceutical and packaged goods for consumers. The
company was founded 132 years ago that is in January 1886. The company is operational in sixty
countries around the globe, but its headquarters is in one Johnson and Johnson Plaza, New
Jersey, Brunswick. Their products are sold in over 170 countries worldwide and just like other
companies Johnson has its website which is www.jnj.com
The company specializes in the production of consumers packaged and pharmaceutical
goods and medical equipment such as surgical materials. These products are such as Johnson and
Johnson is a profit organization. However, they have funded several nonprofit organization to
enable them to achieve their aim of reaching people with health needs widely (Johnson &
Zinkhan, 2015). With Johnson's numerous outlets, they have managed to employ over 134,000
workers in their organizations.
Why Johnson and Johnson?
Johnson and Johnson is a company that offers a pure filed for a student in career or
studies. The company presents students with career opportunities to impact the real world. The
students are offered co-operative programs, internships and even full absorption where they get
to experience continuous support from the company firsthand. Also, there is a connection with
important job assignments through the team and leaders interactions across the company (Chattu,
2015).
Also, through the experience and various opportunities offered, the students can express
their interests and potential. With the global recognition and wide range of products, an
individual is provided the chance to gain knowledge in different fields. With a company like
JOHNSON AND JOHNSON COMPANY.
Johnson that has managed to keep its profit for years despite running in over sixty countries, a
young entrepreneur can learn essential and underlying measures of running and growing a
company.
3
JOHNSON AND JOHNSON COMPANY.
4
References
Johnson, M., & Zinkhan, G. M. (2015). Defining and measuring company image. In Proceedings
of the 1990 Academy of Marketing Science (AMS) Annual Conference(pp. 346-350).
Springer, Cham.
Chattu, V. K. (2015). Corporate social responsibility in public health: A case-study on
HIV/AIDS epidemic by Johnson & Johnson company in Africa. Journal of natural
science, biology, and medicine, 6(1), 219.
Purchase answer to see full
attachment